Quantum Secular Labs / Blog / Advisories

CVE-2026-42933: Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which…

CVE-2026-42933 is rated critical with a CVSS v3.1 base score of 10.0. Per its scoring, it can be exploited over the network, without authentication, without any user interaction. The scored impact on confidentiality, integrity and availability is the highest available.

Vulnerability description

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.

Severity breakdown

CVSS v3.1 10.0: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

  • Attack vector: Network. Exploitable remotely over the network, with no need for local or physical access.
  • Attack complexity: Low. No special conditions; the attack can be repeated reliably.
  • Privileges required: None. No account or prior access is needed.
  • User interaction: None. No action from any user is needed.
  • Scope: Changed. Impact reaches beyond the vulnerable component to other resources.
  • Confidentiality impact: High. Total loss of confidentiality; sensitive data can be fully disclosed.
  • Integrity impact: High. Total loss of integrity; data or system state can be fully modified.
  • Availability impact: High. Total loss of availability; the component can be shut down.

Underlying weakness

CWE-441: Unintended Proxy or Intermediary

The product receives a request, message, or directive from an upstream component, but the product does not sufficiently preserve the original source of the request before forwarding the request to an external actor that is outside of the product's control sphere.

Affected products

    References